224 related articles for article (PubMed ID: 3817172)
21. Appearance of hCG in pregnancy plasma following the initiation of implantation of the blastocyst.
Catt KJ; Dufau ML; Vaitukaitis JL
J Clin Endocrinol Metab; 1975 Mar; 40(3):537-40. PubMed ID: 1117063
[TBL] [Abstract][Full Text] [Related]
22. Detection of beta subunit HCG in plasma of IUD users as an indication of frequency of conception.
Nilsson CG; Lähteenmäki P; Luukkainen T
Int J Fertil; 1979; 24(2):134-7. PubMed ID: 40908
[TBL] [Abstract][Full Text] [Related]
23. Hormonal profile in IUD users.
Souka AR; Rahman H; Osman M; Mohei Y; Rizk M
Contracept Deliv Syst; 1981 Oct; 2(4):303-10. PubMed ID: 12336991
[TBL] [Abstract][Full Text] [Related]
24. New studies link IUDs, infertility; say copper devices safer.
Contracept Technol Update; 1985 Jun; 6(6):81-3. PubMed ID: 12313655
[TBL] [Abstract][Full Text] [Related]
25. Serum prolactin levels in lactating women using progestasert system.
Badraoui MH; Askalani H; Mahrous I; Osman MI; Bayad MA; Ibrahim II; Abdalla MT
Popul Sci; 1981; (2):115-20. PubMed ID: 12339477
[TBL] [Abstract][Full Text] [Related]
26. Intrauterine devices: an effective alternative to oral hormonal contraception.
Prescrire Int; 2009 Jun; 18(101):125-30. PubMed ID: 19637436
[TBL] [Abstract][Full Text] [Related]
27. Intrauterine devices. The optimal long-term contraceptive method?
Fortney JA; Feldblum PJ; Raymond EG
J Reprod Med; 1999 Mar; 44(3):269-74. PubMed ID: 10202746
[TBL] [Abstract][Full Text] [Related]
28. Copper T380 intrauterine device for emergency contraception: highly effective at any time in the menstrual cycle.
Turok DK; Godfrey EM; Wojdyla D; Dermish A; Torres L; Wu SC
Hum Reprod; 2013 Oct; 28(10):2672-6. PubMed ID: 23945595
[TBL] [Abstract][Full Text] [Related]
29. Incidence of early loss of pregnancy.
Wilcox AJ; Weinberg CR; O'Connor JF; Baird DD; Schlatterer JP; Canfield RE; Armstrong EG; Nisula BC
N Engl J Med; 1988 Jul; 319(4):189-94. PubMed ID: 3393170
[TBL] [Abstract][Full Text] [Related]
30. Morphological changes in tubal mucosa associated with the use of intrauterine contraceptive devices.
Wollen AL; Flood PR; Sandvei R; Steier JA
Br J Obstet Gynaecol; 1984 Nov; 91(11):1123-8. PubMed ID: 6498128
[TBL] [Abstract][Full Text] [Related]
31. Relationship of oral contraceptives and the intrauterine contraceptive devices to the regression of concentrations of the beta subunit of human chorionic gonadotropin and invasive complications after molar pregnancy.
Ho Yuen B; Burch P
Am J Obstet Gynecol; 1983 Jan; 145(2):214-7. PubMed ID: 6849356
[TBL] [Abstract][Full Text] [Related]
32. Fertility regulation technology: status and prospects.
Segal SJ; Nordberg OS
Popul Bull; 1977 Mar; 31(6):1-25. PubMed ID: 12335682
[TBL] [Abstract][Full Text] [Related]
33. [IUDs and ectopic pregnancy].
Sivin I
Contracept Fertil Sex (Paris); 1983 Dec; 11(12):1287-94. PubMed ID: 12312723
[TBL] [Abstract][Full Text] [Related]
34. Demonstration of gonadotropin during the second half of the cycle in women using intrauterine contraception.
Beling CG; Cederqvist LL; Fuchs F
Am J Obstet Gynecol; 1976 Jul; 125(6):855-8. PubMed ID: 937412
[TBL] [Abstract][Full Text] [Related]
35. [The end of IUD marketing in the United States: what does it mean for American women?].
Forrest JD
Contracept Fertil Sex (Paris); 1987 Mar; 15(3):291-300. PubMed ID: 12341479
[TBL] [Abstract][Full Text] [Related]
36. Absence of hCG-like activity in the blood of women fitted with intra-uterine contraceptive devices.
Sharpe RM; Wrixon W; Hobson BM; Corker CS; McLean HA; Short RV
J Clin Endocrinol Metab; 1977 Sep; 45(3):496-9. PubMed ID: 903400
[TBL] [Abstract][Full Text] [Related]
37. Trophoblastic markers in women using intrauterine contraception.
Ylikorkala O; Siljander M; Huhtaniemi I; Kauppila A; Seppälä M
Obstet Gynecol; 1980 Mar; 55(3):329-32. PubMed ID: 6965779
[TBL] [Abstract][Full Text] [Related]
38. Quantitative immunologic assay of human chorionic gonadotropin in normal and abnormal pregnancies.
Mishell DR; Davajan V
Am J Obstet Gynecol; 1966 Sep; 96(2):231-9. PubMed ID: 5921063
[TBL] [Abstract][Full Text] [Related]
39. Evaluation of methods for the prospective identification of early fetal losses in environmental epidemiology studies.
Sweeney AM; Meyer MR; Aarons JH; Mills JL; LaPorte RE
Am J Epidemiol; 1988 Apr; 127(4):843-50. PubMed ID: 3354549
[TBL] [Abstract][Full Text] [Related]
40. Comparative contraceptive effectiveness of levonorgestrel-releasing and copper intrauterine devices: the European Active Surveillance Study for Intrauterine Devices.
Heinemann K; Reed S; Moehner S; Minh TD
Contraception; 2015 Apr; 91(4):280-3. PubMed ID: 25601350
[TBL] [Abstract][Full Text] [Related]
[Previous] [Next] [New Search]
